Novo Nordisk, driving change to defeat diabetes

Insulin 100

A century of innovation in diabetes care
COVID-19 & diabetes

If you have questions about physical and mental concerns during COVID-19, click the link below.
COVID-19 & obesity

If you live with obesity, staying home for a prolonged period can make weight management difficult.

Novo Nordisk files for EU regulatory approval of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes

Novo Nordisk files for EU regulatory approval of once-weekly semaglutide 2.4 mg for weight management

Novo Nordisk to enter phase 3 development in Alzheimer’s disease with oral semaglutide

Career Opportunities

Dear colleague

Please click here to go directly to our internal career site to view all our current job opening.

Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.

Investors

Share price

Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Annual Report